No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carbazoles / administration & dosage
-
Carbazoles / adverse effects
-
Carbazoles / therapeutic use*
-
Furans
-
Humans
-
Janus Kinase 2 / antagonists & inhibitors*
-
Janus Kinase Inhibitors / administration & dosage
-
Janus Kinase Inhibitors / adverse effects
-
Janus Kinase Inhibitors / therapeutic use*
-
Primary Myelofibrosis / diagnosis
-
Primary Myelofibrosis / drug therapy*
-
Primary Myelofibrosis / metabolism
-
Treatment Outcome
Substances
-
Carbazoles
-
Furans
-
Janus Kinase Inhibitors
-
lestaurtinib
-
JAK2 protein, human
-
Janus Kinase 2